Last update 08 May 2025

HRG-2010

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target-
Action-
Mechanism-
Therapeutic Areas
Nervous System DiseasesEndocrinology and Metabolic DiseaseOther Diseases
Active Indication
Motor DisordersParkinson Disease
Inactive Indication-
Originator Organization
Jiangsu Hengrui Pharmaceuticals Co., Ltd.Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Active Organization
Jiangsu Hengrui Pharmaceuticals Co., Ltd.Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

4
Clinical Trials associated with HRG-2010
NCT06596876
/ RecruitingPhase 3
A Randomized, Controlled, Double-blind, Double-dummy, Multicenter Phase III Study to Evaluate the Efficacy and Safety of HRG2010 in Parkinson's Disease With Motor Fluctuations
CTR20231044
/ Active, not recruitingPhase 2
HRG2010对比卡左双多巴缓释片治疗帕金森病伴症状波动的药代动力学、药效动力学、有效性和安全性研究—随机、开放、单、多次给药II期临床试验
[Translation] A randomized, open-label, single-dose and multiple-dose phase II clinical trial of HRG2010 versus carbendazim and levodopa sustained-release tablets in the treatment of Parkinson's disease with symptom fluctuations: pharmacokinetic, pharmacodynamic, efficacy and safety
NCT06614153
/ CompletedPhase 2
A Randomized, Open-label, Controlled, Single-dose, Multiple-dose Phase II Study to Evaluate the Pharmacokinetics,Pharmacodynamics,Efficacy and Safety of HRG2010 in Parkinson's Disease Patients With Motor Fluctuations
100 Clinical Results associated with HRG-2010
Login to view more data
100 Translational Medicine associated with HRG-2010
Login to view more data
100 Patents (Medical) associated with HRG-2010
Login to view more data
100 Deals associated with HRG-2010
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Motor DisordersPhase 3
China
Jiangsu Hengrui Pharmaceuticals Co., Ltd.Jiangsu Hengrui Pharmaceuticals Co., Ltd.
06 Nov 2024
Parkinson DiseasePhase 3
China
Jiangsu Hengrui Pharmaceuticals Co., Ltd.Jiangsu Hengrui Pharmaceuticals Co., Ltd.
06 Nov 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free